Fri, Dec 19, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

FSB publishes reports on OTC market reform

Monday, September 02, 2013
Opalesque Industry Update - The Financial Stability Board (FSB) published a report by the FSB Chairman to the G20 Leaders summarising progress in over-the-counter (OTC) derivatives reforms, together with the sixth of the FSB’s semi-annual comprehensive progress reports on implementation of OTC derivatives market reforms.

G20 Leaders agreed in 2009 to a comprehensive reform agenda to improve transparency in these markets, mitigate systemic risk, and protect against market abuse. To achieve these objectives, the G20 agreed that by end-2012:

  • all OTC derivatives contracts should be reported to trade repositories (TRs);
  • all standardised contracts should be traded on exchanges or electronic trading platforms, where appropriate, and cleared through central counterparties (CCPs);
  • non-centrally cleared contracts should be subject to higher capital requirements and minimum margining requirements should be developed. These reports find that substantial progress has been made standard-setting bodies, national and regional authorities and market participants toward meeting the G20 commitments, through international policy development, adoption of legislation and regulation, and expansion of infrastructure.
  • Jurisdictions’ implementation of reforms: By the start of 2014 three-quarters of FSB member jurisdictions intend to have legislation and regulation adopted to require transactions to be reported to trade repositories. Frameworks for central clearing requirements are in place in most of the largest derivatives markets, with concrete rules now starting to go into effect.
  • International standards: minimum standards are in place for sound risk management of Financial Market Infrastructures (FMIs), including CCPs, supporting OTC derivatives markets. Guidance on FMI recovery and resolution has been proposed, to avoid a situation in which these institutions would otherwise be ‘too big to fail’. Standards for margin requirements and capital requirements related to non-centrally cleared transactions have been agreed or proposed, which once implemented will promote sound risk management and encourage use of central clearing.
  • A group of regulators from a number of large OTC derivatives markets have reached understandings to improve the cross-border implementation of OTC derivatives reforms.
  • A macroeconomic assessment estimates long-run net benefits from the reforms. A special focus of the sixth progress report is an exploration of market participant readiness to meet the requirements of reform as they are implemented. If finds that:
  • Market participants in general appear to be making good progress in their preparations for implementation of OTC derivatives market reforms.
  • Actual use of centralised infrastructure by market participants is most advanced in trade reporting and central clearing of OTC interest rate and credit derivatives.
  • The large share of cross-border activity in many OTC derivatives markets means that clarity in how jurisdictions’ regulatory regimes interact is crucial for all stakeholders. The reports also discuss areas where further work is needed to complete the reforms and achieve the G20 objectives, including:
  • increased use of central clearing, and a renewed focus on the commitment to increase the use of exchanges and electronic trading platforms;
  • establishment of resolution regimes for FMIs, including CCPs;
  • continued work by regulators to cooperate in the application of regulations in cross-border contexts, to enable them to defer to each other’s rules where these achieve similar outcomes;
  • greater clarity from regulators regarding the detailed rules on the treatment of cross-border transactions and the timetables for implementation; and
  • ensuring that authorities can make full use of the data collected by trade repositories in fulfilling their financial stability mandates, including via the aggregation of TR data.
Authorities should continue their monitoring to ensure that jurisdictions finalise their reform programmes and to identify new risks that may emerge as market participants adapt to the new regulatory environment.

The FSB will continue to monitor jurisdictions’ implementation of the OTC derivatives reform programme, as well as the extent to which the implemented reforms meet the G20’s underlying goals of improving transparency in the derivatives markets, mitigating systemic risk, and protecting against market abuse. The FSB will publish its next progress report in April 2014.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. Opalesque Exclusive: U.S. legal receivables fund launched in August[more]

    Benedicte Gravrand, Opalesque Geneva for New Managers: Investing in asset-backed receivables is a strategy that has been an integral part of the alternative investment space within the overall fixed income asset c

  5. Comment - High fees and low performance hit hedge funds[more]

    From FT.com: Disenchantment over high fees and lackluster performance may finally be turning the tide against hedge funds, fresh data suggest. Despite generally weak returns since the global financial crisis, hedge funds have enjoyed positive net inflows every year since 2010. This helped assets und